Medication info
Levobalsartan 2.5/80 milligrams

Levobalsartan 2.5/80 milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Anguk New Pharm Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201903023 · Approved 2019.05.10 · Insurance code 053601200

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual component (S-amlodipine (amlodipine) or valsartan); however, switching directly to this medicine may be considered if blood pressure is not controlled with monotherapy using an individual component, as follows. ㆍ 2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 80 milligrams. ㆍ 2.5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 160 milligrams. ㆍ 5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 5 milligrams (amlodipine 10 milligrams) or valsartan 160 milligrams, or with 2.5/160 milligrams. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Anguk New Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication helps effectively control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with S-Amlodipine (Amlodipine) or Valsartan. This is used to maintain health by reducing the risk of complications associated with hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual component (S-amlodipine (amlodipine) or valsartan); however, switching directly to this medicine may be considered if blood pressure is not controlled with monotherapy using an individual component, as follows. ㆍ 2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 80 milligrams. ㆍ 2.5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 160 milligrams. ㆍ 5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy of S-amlodipine 5 milligrams (amlodipine 10 milligrams) or valsartan 160 milligrams, or with 2.5/160 milligrams. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn, particularly during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. It is contraindicated in patients with allergies to the active ingredient or similar components, in pregnant or breastfeeding women, in patients with severe kidney or liver disease, in patients with certain heart diseases, etc. Patients with low sodium or fluid levels in the body must improve their condition before taking this medication, and if symptoms of hypotension occur during use, immediate appropriate action must be taken. Patients with elevated potassium levels or those taking medications that can increase potassium levels should have their potassium levels checked frequently. Patients with impaired renal function, transplant recipients, those with a history of angioedema, patients with heart failure or myocardial infarction, etc., should take this medication with caution and under close observation by a doctor. This medication may cause dizziness or fatigue, requiring caution when driving or operating machinery. In case of overdose, hypotension, dizziness, and in severe cases, shock may occur, necessitating immediate medical attention. It is important to regularly check blood pressure, kidney function, electrolyte levels, etc., to detect any abnormalities while taking this medication. Additionally, there may be potential interactions with other antihypertensives, potassium supplements, certain diuretics, anti-inflammatory medications, etc., so it is essential to consult a doctor or pharmacist. Elderly patients may take the usual dosage, but caution may be necessary depending on their physical condition. Finally, this medication is not recommended for children under 18 years of age, as its safety and efficacy have not been sufficiently established.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, sweating, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, generalized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be kept at room temperature, between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.